Quantitative assessment of mammographic breast density: relationship with breast cancer risk.

Increased mammographic breast density is a moderate independent risk factor for breast cancer, with findings of published studies in which quantitative methods of assessment were used showing a positive association. Breast density may be quantified by using visual assessment or planimetry. Although the category definitions vary, the odds ratio for developing breast cancer for the most dense compared with the least dense breast tissue categories ranges from 1.8 to 6.0, with most studies yielding an odds ratio of 4.0 or greater. Plausible explanations for the association of breast density with increased breast cancer risk may be the development of premalignant lesions such as atypical ductal hyperplasia, elevated growth factors, or increased estrogen production within the breast due to overactive aromatase. The amount of breast density may be due in part to genetic heredity. However, unlike other risk factors, breast density may be influenced. Specifically, breast density is very hormonally responsive and potentially may be influenced by lifestyle factors such as alcohol intake and diet. Assessment of breast density may become useful in risk assessment and prevention decisions.

[1]  Navin Parekh,et al.  Effects of mammographic density and benign breast disease on breast cancer risk (United States) , 2001, Cancer Causes & Control.

[2]  G. Maskarinec,et al.  A case-control study of mammographic densities in Hawaii , 2000, Breast Cancer Research and Treatment.

[3]  T. Sellers,et al.  Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States) , 2000, Cancer Causes & Control.

[4]  E. Weiderpass,et al.  Risks of breast and endometrial cancer after estrogen and estrogen–progestin replacement , 1999, Cancer Causes & Control.

[5]  J. Otten,et al.  Mammographic breast density and risk of breast cancer: Masking bias or causality? , 1998, European Journal of Epidemiology.

[6]  Ikuko Kato,et al.  A nested case-control study of mammographic patterns, breast volume, and breast cancer (New York City, NY, United States) , 1995, Cancer Causes & Control.

[7]  Mark A Helvie,et al.  Invasive cancers detected after breast cancer screening yielded a negative result: relationship of mammographic density to tumor prognostic factors. , 2004, Radiology.

[8]  B. Zee,et al.  Mammographic density changes in perimenopausal and postmenopausal women: is effect of hormone replacement therapy predictable? , 2004, Breast Cancer Research and Treatment.

[9]  Karla Kerlikowske,et al.  Mammographic breast density and family history of breast cancer. , 2003, Journal of the National Cancer Institute.

[10]  Zhimin Huo,et al.  Computerized analysis of digitized mammograms of BRCA1 and BRCA2 gene mutation carriers. , 2002, Radiology.

[11]  N F Boyd,et al.  The association of breast mitogens with mammographic densities , 2002, British Journal of Cancer.

[12]  David Tritchler,et al.  Heritability of mammographic density, a risk factor for breast cancer. , 2002, The New England journal of medicine.

[13]  David Gur,et al.  Computerized assessment of tissue composition on digitized mammograms. , 2002, Academic radiology.

[14]  M. Helvie,et al.  Decreasing rate of fatty involution at screening mammography. , 2002, Academic radiology.

[15]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[16]  M. Blankenstein,et al.  Effect of tibolone (Org OD14) and its metabolites on aromatase and estrone sulfatase activity in human breast adipose stromal cells and in MCF-7 and T47D breast cancer cells , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[17]  S. Duffy,et al.  Mammographic parenchymal patterns and self-reported soy intake in Singapore Chinese women. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[18]  L. Liberman,et al.  Breast imaging reporting and data system (BI-RADS). , 2002, Radiologic clinics of North America.

[19]  John A Shepherd,et al.  Measurement of breast density with dual X-ray absorptiometry: feasibility. , 2002, Radiology.

[20]  B. V. VON Schoultz,et al.  Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density. , 2002, American journal of obstetrics and gynecology.

[21]  S. Cummings,et al.  Serum estradiol level and risk of breast cancer during treatment with raloxifene. , 2002, JAMA.

[22]  A. Trosclair,et al.  Cigarette smoking among adults--United States, 2000. , 2002, MMWR. Morbidity and mortality weekly report.

[23]  F. Sendag,et al.  Mammographic density changes during different postmenopausal hormone replacement therapies. , 2001, Fertility and sterility.

[24]  P. Franciscis,et al.  Effects of a short-term suspension of hormone replacement therapy on mammographic density. , 2001, Fertility and sterility.

[25]  N. Obuchowski,et al.  Automatic segmentation of mammographic density. , 2001, Academic radiology.

[26]  N F Boyd,et al.  Growth factors and stromal matrix proteins associated with mammographic densities. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[27]  M. Pike,et al.  Mammographic density changes during the menstrual cycle. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[28]  C M Rutter,et al.  Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. , 2001, JAMA.

[29]  M. Freedman,et al.  Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo. , 2001, Journal of the National Cancer Institute.

[30]  S. Duffy,et al.  Mammographic parenchymal patterns and breast cancer natural history--a case-control study. , 2001, Acta oncologica.

[31]  J. Brisson,et al.  Tamoxifen and mammographic breast densities. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[32]  B. Geller,et al.  The association of increased weight, body mass index, and tissue density with the risk of breast carcinoma in Vermont , 2000, Cancer.

[33]  W. Willett,et al.  Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. , 2000, Cancer research.

[34]  J. Yager,et al.  Tissue-specific synthesis and oxidative metabolism of estrogens. , 2000, Journal of the National Cancer Institute. Monographs.

[35]  M. Pike,et al.  Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. , 2000, Journal of the National Cancer Institute.

[36]  Berkman Sahiner,et al.  Computerized image analysis: estimation of breast density on mammograms , 2000, Medical Imaging: Image Processing.

[37]  P. Langenberg,et al.  Breast Imaging Reporting and Data System: inter- and intraobserver variability in feature analysis and final assessment. , 2000, AJR. American journal of roentgenology.

[38]  R. Hoover,et al.  Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. , 2000, JAMA.

[39]  J. Otten,et al.  Parity and mammographic breast density in relation to breast cancer risk: indication of interaction. , 2000, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[40]  J. White Breast density and cancer risk: what is the relationship? , 2000, Journal of the National Cancer Institute.

[41]  J. Cerhan,et al.  Association of diet and mammographic breast density in the Minnesota breast cancer family cohort. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[42]  S. Cummings,et al.  The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women: Results From the MORE Randomized Trial , 2000 .

[43]  S. Haslam,et al.  Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. , 1999, The Journal of clinical endocrinology and metabolism.

[44]  N Karssemeijer,et al.  Changes in mammographic breast density and concomitant changes in breast cancer risk. , 1999, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[45]  S. Duffy,et al.  High-risk mammographic parenchymal patterns and anthropometric measures: a case–control study , 1999, British Journal of Cancer.

[46]  T. Sellers,et al.  Preliminary sibpair linkage analysis of percent mammographic density. , 1999, Journal of the National Cancer Institute.

[47]  N. Boyd,et al.  Mammographic densities and risk of breast cancer among subjects with a family history of this disease. , 1999, Journal of the National Cancer Institute.

[48]  B. V. VON Schoultz,et al.  Mammographic breast density during hormone replacement therapy: differences according to treatment. , 1999, American journal of obstetrics and gynecology.

[49]  R. Santen,et al.  Aromatase within the breast. , 1999, Endocrine-related cancer.

[50]  J. Manson,et al.  Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. , 1999, Journal of the National Cancer Institute.

[51]  T. Anderson Pathological studies of apoptosis in the normal breast. , 1999, Endocrine-related cancer.

[52]  Linda Olson,et al.  Effects of Estrogen and EstrogenProgestin on Mammographic Parenchymal Density , 1999, Annals of Internal Medicine.

[53]  N. Boyd,et al.  Macronutrient intake and change in mammographic density at menopause: results from a randomized trial. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[54]  L. Tabár,et al.  Moderate physical activity in relation to mammographic patterns. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[55]  C K Redmond,et al.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.

[56]  K. Kerlikowske,et al.  Variability and accuracy in mammographic interpretation using the American College of Radiology Breast Imaging Reporting and Data System. , 1998, Journal of the National Cancer Institute.

[57]  N. Boyd,et al.  Mammographic densities and breast cancer risk. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[58]  N. Boyd,et al.  Analysis of mammographic density and breast cancer risk from digitized mammograms. , 1998, Radiographics : a review publication of the Radiological Society of North America, Inc.

[59]  E White,et al.  Variation in mammographic breast density by time in menstrual cycle among women aged 40-49 years. , 1998, Journal of the National Cancer Institute.

[60]  N Karssemeijer,et al.  Automated classification of parenchymal patterns in mammograms. , 1998, Physics in medicine and biology.

[61]  C. Herman,et al.  Short-term cessation of hormone replacement therapy and improvement of mammographic specificity. , 1997, Journal of the National Cancer Institute.

[62]  I Persson,et al.  Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  C. Byrne,et al.  Studying mammographic density: implications for understanding breast cancer. , 1997, Journal of the National Cancer Institute.

[64]  J. Pankow,et al.  Genetic analysis of mammographic breast density in adult women: evidence of a gene effect. , 1997, Journal of the National Cancer Institute.

[65]  N. Boyd,et al.  Effects at two years of a low-fat, high-carbohydrate diet on radiologic features of the breast: results from a randomized trial. Canadian Diet and Breast Cancer Prevention Study Group. , 1997, Journal of the National Cancer Institute.

[66]  H Rusinek,et al.  Fatty and fibroglandular tissue volumes in the breasts of women 20-83 years old: comparison of X-ray mammography and computer-assisted MR imaging. , 1997, AJR. American journal of roentgenology.

[67]  L. Skoog,et al.  Proliferation of breast epithelial cells in healthy women during the menstrual cycle. , 1997, American journal of obstetrics and gynecology.

[68]  P. Stomper,et al.  Analysis of parenchymal density on mammograms in 1353 women 25-79 years old. , 1996, AJR. American journal of roentgenology.

[69]  G. Chetrite,et al.  Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. , 1996, The Journal of clinical endocrinology and metabolism.

[70]  S. J. Graham,et al.  Quantitative correlation of breast tissue parameters using magnetic resonance and X-ray mammography. , 1996, British Journal of Cancer.

[71]  D B Plewes,et al.  Changes in fibroglandular volume and water content of breast tissue during the menstrual cycle observed by MR imaging at 1.5 t , 1995, Journal of magnetic resonance imaging : JMRI.

[72]  J. Wolfe,et al.  Mammographic features and breast cancer risk: effects with time, age, and menopause status. , 1995, Journal of the National Cancer Institute.

[73]  N F Boyd,et al.  Parenchymal patterns of the breast defined by real time ultrasound. , 1995, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[74]  N. Boyd,et al.  Quantitative evaluation of mammographic densities: a comparison of methods of assessment. , 1995, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[75]  E B Larson,et al.  Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. , 1995, Radiology.

[76]  E. Fishell,et al.  Mammographic densities as a criterion for entry to a clinical trial of breast cancer prevention. , 1995, British Journal of Cancer.

[77]  A. Miller,et al.  Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. , 1995, Journal of the National Cancer Institute.

[78]  D. Macerlaine,et al.  Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study. , 1994, AJR. American journal of roentgenology.

[79]  M. Pike,et al.  Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. , 1994, Journal of the National Cancer Institute.

[80]  E. Sickles,et al.  Association of abnormal nipple aspirate cytology and mammographic pattern and density. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[81]  A. Oza,et al.  Mammographic parenchymal patterns: a marker of breast cancer risk. , 1993, Epidemiologic reviews.

[82]  N. Boyd,et al.  Relationship between mammographic and histological risk factors for breast cancer. , 1992, Journal of the National Cancer Institute.

[83]  Parkin Dm,et al.  Cancer Incidence in Five Continents. Comparability and quality of data. , 1992 .

[84]  D M Parkin,et al.  Cancer Incidence in Five Continents. Comparability and quality of data. , 1992, IARC scientific publications.

[85]  R N Hoover,et al.  Mammographic densities and risk of breast cancer , 1991, Cancer.

[86]  M. Michell,et al.  The mammographic parenchymal patterns of women on hormonal replacement therapy. , 1991, Clinical radiology.

[87]  I. Ellis,et al.  The relationship of "high risk" mammographic patterns to histological risk factors for development of cancer in the human breast. , 1990, The British journal of radiology.

[88]  P. Stomper,et al.  Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study. , 1990, Radiology.

[89]  J. Berkowitz,et al.  Hormonal replacement therapy: mammographic manifestations. , 1990, Radiology.

[90]  A. Morrison,et al.  Diet, mammographic features of breast tissue, and breast cancer risk. , 1989, American journal of epidemiology.

[91]  A. Morrison,et al.  Relationship between mammographic and histologic features of breast tissue in women with benign biopsies. , 1988, Cancer.

[92]  N. Boyd,et al.  The association of histological and radiological indicators of breast cancer risk. , 1988, British Journal of Cancer.

[93]  J. Wolfe,et al.  Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study. , 1987, AJR. American journal of roentgenology.

[94]  M. Szklo,et al.  Mammographic parenchymal patterns and breast cancer risk. , 1987, Epidemiologic reviews.

[95]  D. Page,et al.  The dense mammogram. , 1986, AJR. American journal of roentgenology.

[96]  A. Morrison,et al.  Height and weight, mammographic features of breast tissue, and breast cancer risk. , 1984, American journal of epidemiology.

[97]  S. Brünner,et al.  The risk of developing breast cancer in relation to mammography findings. , 1984, European journal of radiology.

[98]  D. Thompson,et al.  Reproducibility and consistency in classification of breast parenchymal patterns. , 1983, AJR. American journal of roentgenology.

[99]  F Merletti,et al.  Mammographic features of the breast and breast cancer risk. , 1982, American journal of epidemiology.

[100]  E. Fishell,et al.  Radio-free America: what to do with the waste. , 1994, Environmental health perspectives.

[101]  L. Tabár,et al.  Mammographic parenchymal patterns. Risk indicator for breast cancer? , 1982, JAMA.

[102]  J. Norbeck,et al.  Association between mammographic parenchymal pattern classification and incidence of breast cancer , 1980, Cancer.

[103]  M Moskowitz,et al.  Mammographic patterns as markers for high-risk benign breast disease and incident cancers. , 1980, Radiology.

[104]  R. Egan,et al.  Mammographic parenchymal patterns and risk of breast cancer. , 1979, Radiology.

[105]  R L Egan,et al.  Breast cancer mammography patterns. , 1977, Cancer.

[106]  J. Wolfe Breast patterns as an index of risk for developing breast cancer. , 1976, AJR. American journal of roentgenology.